Obesity drug semaglutide fails to slow Alzheimer’s

Drug maker Novo Nordisk says semaglutide, the active ingredient for the weight loss jab Wegovy, does not slow Alzheimer’s – despite initial hopes that it might help against dementia. Researchers began two large trials involving more than 3,800 people after reports the medicine was having an impact in the real world. But the studies showed…

Read More

Client Challenge

Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser. Source link

Read More